Abstract
There are several tetraspanins present in platelets including CD9, CD151, TSSC6, and CD63. Recent studies in knockout mouse models have revealed that CD151 and TSSC6 are physically and functionally involved in regulation of the ‘outside-in’ signalling properties of the major platelet integrin, integrin αIIbβ3 and thrombus stability in vivo.
Keywords: Tetraspanin, integrin αIIbβ3, outside-in signalling, platelet thrombus formation
Mini-Reviews in Medicinal Chemistry
Title: Tetraspanins-Structural and Signalling Scaffolds that Regulate Platelet Function
Volume: 7 Issue: 12
Author(s): Matt W. Goschnick and Denise E. Jackson
Affiliation:
Keywords: Tetraspanin, integrin αIIbβ3, outside-in signalling, platelet thrombus formation
Abstract: There are several tetraspanins present in platelets including CD9, CD151, TSSC6, and CD63. Recent studies in knockout mouse models have revealed that CD151 and TSSC6 are physically and functionally involved in regulation of the ‘outside-in’ signalling properties of the major platelet integrin, integrin αIIbβ3 and thrombus stability in vivo.
Export Options
About this article
Cite this article as:
Goschnick W. Matt and Jackson E. Denise, Tetraspanins-Structural and Signalling Scaffolds that Regulate Platelet Function, Mini-Reviews in Medicinal Chemistry 2007; 7 (12) . https://dx.doi.org/10.2174/138955707782795656
DOI https://dx.doi.org/10.2174/138955707782795656 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Atherosclerosis - New Targets and Therapeutics
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Mast Cells as Target in Cancer Therapy
Current Pharmaceutical Design Plasmid DNA-based Gene Transfer with Ultrasound and Microbubbles
Current Gene Therapy Microbubbles as Drug Delivery Systems in Cerebrovascular Diseases
Recent Patents on Cardiovascular Drug Discovery The Recurrent Mediastinal Bronchogenic Cyst: A Benign Tumour with an Invasive Character: Case Report
Current Respiratory Medicine Reviews The Pathophysiology of Heme in the Brain
Current Alzheimer Research Enhanced Bioavailability of Curcumin Nanoemulsions Stabilized with Phosphatidylcholine Modified with Medium Chain Fatty Acids
Current Drug Delivery Coronary Artery Disease and Endothelial Dysfunction: Novel Diagnostic and Therapeutic Approaches
Current Medicinal Chemistry Non-Steroidal Anti-Inflammatory Drugs used as a Treatment Modality in Subarachnoid Hemorrhage
Current Drug Safety Malaria, Anti Malarial Drugs and the Role of Melatonin
Infectious Disorders - Drug Targets Cardiovascular Physiology of Androgens and Androgen Testosterone Therapy in Postmenopausal Women
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Novel Biomarkers of Cardiovascular Disease in Chronic Kidney Disease: Focus on Adiponectin and Leptin
Current Cardiology Reviews Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases
Current Medicinal Chemistry Pleiotropic Effects of Statins: Stabilization of the Vulnerable Atherosclerotic Plaque?
Current Pharmaceutical Design Imaging Subclinical Atherosclerosis: Where Do We Stand?
Current Cardiology Reviews The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer
Current Drug Targets Treatment of Tachycardia in Hypertension: Where Do We Stand Now?
Current Hypertension Reviews Ezetimibe and Reactive Oxygen Species
Current Vascular Pharmacology Adiponectin and its Role in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm
Current Drug Targets